Showing results (781-790 of 798) with videos related to
Sort By:
Pageof 80
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|August 30, 2017
UV Index monitoring in EuropeAlois W Schmalwieser, Julian Gröbner, Mario Blumthaler, et al.Journal of Virology|October 6, 2017
Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in HumansAlba Grifoni, John Pham, John Sidney, et al.Nature|February 1, 2022
T cell responses to SARS-CoV-2 spike cross-recognize OmicronRoanne Keeton, Marius B Tincho, Amkele Ngomti, et al.Journal of Thrombosis and Haemostasis : JTH|May 15, 2012
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter studyF Dentali, D Poli, U Scoditti, et al.Science Translational Medicine|August 17, 2022
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccinePrabhu S Arunachalam, Yupeng Feng, Usama Ashraf, et al.Science (New York, N.Y.)|October 14, 2021
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concernRishi R Goel, Mark M Painter, Sokratis A Apostolidis, et al.Biorxiv : the Preprint Server for Biology|August 31, 2021
mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of ConcernRishi R Goel, Mark M Painter, Sokratis A Apostolidis, et al.PLOS Global Public Health|April 11, 2024
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participantsCatherine Riou, Jinal N Bhiman, Yashica Ganga, et al.Medrxiv : the Preprint Server for Health Sciences|December 4, 2023
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participantsCatherine Riou, Jinal N Bhiman, Yashica Ganga, et al.Nature|May 3, 2016
The genetic history of Ice Age EuropeQiaomei Fu, Cosimo Posth, Mateja Hajdinjak, et al.Pageof 80